by Gillian Rutherford, University of Alberta Graphical abstract. Credit: Stem Cell Reports (2023). DOI: 10.1016/j.stemcr.2022.12.001 A University of Alberta researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases. Multiple sclerosis is an autoimmune disease in which the...
